12:00 AM
 | 
Sep 24, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

PolyTherics, Pro Bono Bio preclinical data

In dogs with hemophilia, subcutaneous long-acting pegylated Factor VIII prolonged the amount of time free from bleeding risk by 72 hours vs. 0 hours for unmodified Factor VIII. Additionally, IV...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >